Uncategorized

AlzeCure Pharma AB announced that its interim report for the period January – March 2023 is now available on the company’s website.

Hasten Biopharmaceutic Co., Ltd announced that it has acquired the commercial rights in China for Rocephin®, a long-acting, broad spectrum cephalosporin antibiotic, from Swiss multinational healthcare company, Roche.

PureTech Health plc, a clinical-stage biotherapeutics company noted that its Founded Entity, Akili, Inc., a leading digital medicine company, announced topline results of the STARS-ADHD-Adult clinical trial evaluating the efficacy and safety of EndeavorRxⓇ in adults with attention-deficit/hyperactivity disorder.

Mekonos, Inc. has announced a new research collaboration with bit.bio, a synthetic biology company providing human cells for research, drug discovery and cell therapy.

[Pamplona, Covina] – The Foundation for Prader Willi Research (FPWR) has provided a new venture philanthropy award, in the form of a convertible loan, to Palobiofarma S.L., a Spanish biopharmaceutical company focused on developing innovative treatments for serious diseases.

The regulatory decision marks a turning point in the RSV race in what’s expected to be a competitive space.

Enrollment in MA plans has steadily increased since 2007, when one in five Medicare beneficiaries were enrolled in a private plan.

The company plans to quickly submit an application for U.S. approval based on the trial results, which showed a consistent benefit to treatment with the drug.

The company’s recent big-ticket acquisitions are taking a toll on its financial outlook, though management told investors Wednesday the company still expects to reach its prior earnings targets for 2024 and 2025.

The workforce reductions at the scientific instruments maker continue the wave of job cuts affecting the medical device sector in recent months.